{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:22:57Z","timestamp":1791174177539,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1378\/chest.12-0142","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T19:01:15Z","timestamp":1346785275000},"page":"761-773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Relevance of Latent TB Infection in Areas of High TB Prevalence"],"prefix":"10.1016","volume":"142","author":[{"given":"Surendra K.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Mohanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.12-0142_bib1","author":"World Health Organization"},{"issue":"12","key":"10.1378\/chest.12-0142_bib2","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1371\/journal.pmed.0030494","article-title":"Tuberculosis among health-care workers in low- and middle-income countries: a systematic review","volume":"3","author":"Joshi","year":"2006","journal-title":"PLoS Med"},{"issue":"7","key":"10.1378\/chest.12-0142_bib3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2105\/AJPH.30.7.816","article-title":"Mortality in the children of tuberculous households","volume":"30","author":"Brailey","year":"1940","journal-title":"Am J Public Health Nations Health"},{"issue":"3","key":"10.1378\/chest.12-0142_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MCP.0b013e32832a0adc","article-title":"T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings","volume":"15","author":"Dheda","year":"2009","journal-title":"Curr Opin Pulm Med"},{"issue":"9","key":"10.1378\/chest.12-0142_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1378\/chest.12-0142_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrmicro749","article-title":"Tuberculosis: a problem with persistence","volume":"1","author":"Stewart","year":"2003","journal-title":"Nat Rev Microbiol"},{"key":"10.1378\/chest.12-0142_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2334-7-146","article-title":"The role of resuscitation promoting factors in pathogenesis and reactivation of Mycobacterium tuberculosis during intra-peritoneal infection in mice","volume":"7","author":"Biketov","year":"2007","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1378\/chest.12-0142_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1378\/chest.12-0142_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1128\/CVI.00492-10","article-title":"Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals","volume":"18","author":"Commandeur","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1378\/chest.12-0142_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0966-842X(98)01216-5","article-title":"Mechanisms of latency in Mycobacterium tuberculosis","volume":"6","author":"Parrish","year":"1998","journal-title":"Trends Microbiol"},{"issue":"5980","key":"10.1378\/chest.12-0142_bib11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1185449","article-title":"The population dynamics and control of tuberculosis","volume":"328","author":"Dye","year":"2010","journal-title":"Science"},{"issue":"4","key":"10.1378\/chest.12-0142_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1440-1843.2010.01751.x","article-title":"Treatment of latent tuberculosis infection: An update","volume":"15","author":"Lobue","year":"2010","journal-title":"Respirology"},{"issue":"5","key":"10.1378\/chest.12-0142_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1378\/chest.12-0142_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/ajrccm\/145.3.621","article-title":"Effect of Bacille Calmette-Gu\u00e9rin vaccination on tuberculin reactivity","volume":"145","author":"Menzies","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"4 pt 2","key":"10.1378\/chest.12-0142_bib16","first-page":"S221","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.12-0142_bib17","first-page":"111","article-title":"Isolation rates of different mycobacterial species from Chandigarh (north India)","volume":"91","author":"Chakrabarti","year":"1990","journal-title":"Indian J Med Res"},{"issue":"suppl 4","key":"10.1378\/chest.12-0142_bib18","doi-asserted-by":"crossref","first-page":"S1120","DOI":"10.1093\/infdis\/jir410","article-title":"Interferon-\u03b3 release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis","volume":"204","author":"Metcalfe","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1378\/chest.12-0142_bib19","series-title":"Use of Tuberculosis Interferon-Gamma Release Assays (IGRAs) in Low- and Middle-Income Countries: Policy Statement. Publication WHO\/HTM\/TB\/2011 18","author":"World Health Organization","year":"2011"},{"issue":"7","key":"10.1378\/chest.12-0142_bib20","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1086\/382362","article-title":"Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia","volume":"38","author":"Hill","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1378\/chest.12-0142_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1164\/rccm.2506003","article-title":"Interferon-gamma assays for tuberculosis: is anergy the Achilles' heel?","volume":"172","author":"Pai","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.12-0142_bib22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/504358","article-title":"Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers","volume":"27","author":"Harada","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1378\/chest.12-0142_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/thx.2010.143180","article-title":"Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review","volume":"67","author":"Zwerling","year":"2012","journal-title":"Thorax"},{"issue":"1","key":"10.1378\/chest.12-0142_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1378\/chest.12-0142_bib25","doi-asserted-by":"crossref","first-page":"e4220","DOI":"10.1371\/journal.pone.0004220","article-title":"The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis","volume":"4","author":"Aabye","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1378\/chest.12-0142_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-6673-1-7","article-title":"Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report","volume":"1","author":"Pai","year":"2006","journal-title":"J Occup Med Toxicol"},{"issue":"3","key":"10.1378\/chest.12-0142_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1378\/chest.12-0142_bib28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.trstmh.2007.02.001","article-title":"Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The Gambia","volume":"101","author":"Jackson-Sillah","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1378\/chest.12-0142_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1378\/chest.12-0142_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/INF.0b013e318214b915","article-title":"The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis","volume":"30","author":"Machingaidze","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1378\/chest.12-0142_bib31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/thx.2005.048033","article-title":"Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children","volume":"61","author":"Connell","year":"2006","journal-title":"Thorax"},{"key":"10.1378\/chest.12-0142_bib32","series-title":"Use of Interferon-Gamma Release Assays in Support of TB Diagnosis","author":"European Centre for Disease Prevention and Control","year":"2011"},{"key":"10.1378\/chest.12-0142_bib33","series-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. NICE clinical guideline 117","author":"National Collaborating Centre for Chronic Conditions and the Centre for Clinical Practice at NICE","year":"2011"},{"issue":"10","key":"10.1378\/chest.12-0142_bib34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","article-title":"Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial","volume":"149","author":"Menzies","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1378\/chest.12-0142_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1378\/chest.12-0142_bib36","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.12-0142_bib37","first-page":"257","article-title":"Recent developments in treatment of latent tuberculosis infection","volume":"133","author":"Menzies","year":"2011","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1378\/chest.12-0142_bib38","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1164\/rccm.201103-0397OC","article-title":"Short-course chemotherapy with TMC207 and rifapentine in a murine model of latent tuberculosis infection","volume":"184","author":"Zhang","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.12-0142_bib39","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.12-0142_bib40","author":"World Health Organization"},{"issue":"3","key":"10.1378\/chest.12-0142_bib41","first-page":"216","article-title":"Multi-drug resistant tuberculosis: current status and emerging tools for its management in India","volume":"38","author":"Singh","year":"2006","journal-title":"J Commun Dis"},{"key":"10.1378\/chest.12-0142_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2334-8-166","article-title":"Prevalence of tuberculosis drug resistance in 10 provinces of China","volume":"8","author":"He","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1378\/chest.12-0142_bib43","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1309.070070","article-title":"Failure of isoniazid chemoprophylaxis during infliximab therapy","volume":"13","author":"Fern\u00e1ndez-Guerrero","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1378\/chest.12-0142_bib44","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3201\/eid1205.050681","article-title":"Isoniazid preventive therapy and risk for resistant tuberculosis","volume":"12","author":"Balcells","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1378\/chest.12-0142_bib45","series-title":"Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living With HIV in Resource-Constrained Settings","author":"World Health Organization","year":"2011"},{"issue":"2","key":"10.1378\/chest.12-0142_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002030-200101260-00011","article-title":"Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults","volume":"15","author":"Quigley","year":"2001","journal-title":"AIDS"},{"issue":"9777","key":"10.1378\/chest.12-0142_bib47","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Samandari","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"10.1378\/chest.12-0142_bib48","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Hirsch-Moverman","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1378\/chest.12-0142_bib49","first-page":"24","article-title":"Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection","volume":"15","author":"Houben","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"10.1378\/chest.12-0142_bib50","first-page":"406","article-title":"Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa","volume":"14","author":"Wood","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1378\/chest.12-0142_bib51","first-page":"186","article-title":"New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes","volume":"16","author":"Lienhardt","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1378\/chest.12-0142_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(09)70326-3","article-title":"Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis","volume":"10","author":"Kranzer","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1378\/chest.12-0142_bib53","first-page":"55","article-title":"Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997\u20131998","volume":"6","author":"Ansari","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1378\/chest.12-0142_bib54","first-page":"1","article-title":"The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia","volume":"96","author":"Elliott","year":"1993","journal-title":"J Trop Med Hyg"},{"issue":"9578","key":"10.1378\/chest.12-0142_bib55","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(07)60284-0","article-title":"Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes","volume":"369","author":"Getahun","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1378\/chest.12-0142_bib56","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"10.1378\/chest.12-0142_bib57","first-page":"417","article-title":"High level of discordant IGRA results in HIV-infected adults and children","volume":"12","author":"Mandalakas","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1378\/chest.12-0142_bib58","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1473-3099(07)70086-5","article-title":"T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward","volume":"7","author":"Pai","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1378\/chest.12-0142_bib59","doi-asserted-by":"crossref","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","article-title":"Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies","volume":"8","author":"Getahun","year":"2011","journal-title":"PLoS Med"},{"issue":"1","key":"10.1378\/chest.12-0142_bib60","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"9240","key":"10.1378\/chest.12-0142_bib61","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(00)02870-1","article-title":"Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial","volume":"356","author":"Fitzgerald","year":"2000","journal-title":"Lancet"},{"issue":"14","key":"10.1378\/chest.12-0142_bib62","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00002030-200309260-00007","article-title":"Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?","volume":"17","author":"Churchyard","year":"2003","journal-title":"AIDS"},{"issue":"7","key":"10.1378\/chest.12-0142_bib63","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/QAD.0b013e32833849df","article-title":"Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting","volume":"24","author":"van Halsema","year":"2010","journal-title":"AIDS"},{"key":"10.1378\/chest.12-0142_bib64","series-title":"WHO Three I's Meeting: Intensified Case Finding (ICF), Isoniazid Preventive Therapy (IPT) and TB Infection Control (IC) for People Living with HIV","author":"World Health Organization","year":"2008"},{"key":"10.1378\/chest.12-0142_bib65","series-title":"Multidrug and Extensively Drug Resistant TB (M\/SDR-TB): 2010 Global Report on Surveillance and Response. Publication WHO\/HTM\/TB\/2010 3","author":"World Health Organziation","year":"2010"},{"key":"10.1378\/chest.12-0142_bib66","first-page":"312","article-title":"Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients","volume":"133","author":"Sharma","year":"2011","journal-title":"Indian J Med Res"},{"issue":"4","key":"10.1378\/chest.12-0142_bib67","first-page":"321","article-title":"Infection and disease among household contacts of patients with multidrug-resistant tuberculosis","volume":"5","author":"Teixeira","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9760","key":"10.1378\/chest.12-0142_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(10)61972-1","article-title":"Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study","volume":"377","author":"Becerra","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1378\/chest.12-0142_bib69","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"issue":"3","key":"10.1378\/chest.12-0142_bib70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/thx.2008.100974","article-title":"Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort","volume":"64","author":"Attamna","year":"2009","journal-title":"Thorax"},{"issue":"11","key":"10.1378\/chest.12-0142_bib71","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1164\/rccm.200507-1047OC","article-title":"Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model","volume":"172","author":"Nuermberger","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.12-0142_bib72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1473-3099(08)70077-X","article-title":"Minimising moxifloxacin resistance with tuberculosis","volume":"8","author":"Drlica","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1378\/chest.12-0142_bib73","series-title":"Tuberculosis. Textbook of Pediatric Infectious Diseases","first-page":"1337","author":"Starke","year":"2004"},{"issue":"3","key":"10.1378\/chest.12-0142_bib74","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jinf.2006.04.007","article-title":"Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India","volume":"54","author":"Dogra","year":"2007","journal-title":"J Infect"},{"issue":"8","key":"10.1378\/chest.12-0142_bib75","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.5588\/ijtld.10.0631","article-title":"Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis","volume":"15","author":"Mandalakas","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"RR-17","key":"10.1378\/chest.12-0142_bib76","first-page":"1","article-title":"Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings 2005","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1378\/chest.12-0142_bib77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1011214","article-title":"Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children","volume":"365","author":"Madhi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.12-0142_bib78","series-title":"Technical and Operational Guidelines for Tuberculosis Control","author":"Revised National Tuberculosis Control Program","year":"2005"},{"issue":"12","key":"10.1378\/chest.12-0142_bib79","first-page":"1507","article-title":"Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis","volume":"13","author":"Banu Rekha","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"10.1378\/chest.12-0142_bib80","first-page":"650","article-title":"Recording isoniazid preventive therapy delivery to children: operational challenges","volume":"14","author":"Van Wyk","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1378\/chest.12-0142_bib81","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3201\/eid1703.100947","article-title":"Tuberculosis among health care workers","volume":"17","author":"Baussano","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1378\/chest.12-0142_bib82","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/lt.22203","article-title":"Detection and management of latent tuberculosis in liver transplant patients","volume":"17","author":"Jafri","year":"2011","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1378\/chest.12-0142_bib83","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/ndt\/gfp489","article-title":"Use of isoniazid chemoprophylaxis in renal transplant recipients","volume":"25","author":"Naqvi","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1378\/chest.12-0142_bib84","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1523-1755.2004.00586.x","article-title":"Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients","volume":"65","author":"Sester","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1378\/chest.12-0142_bib85","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/ndt\/gfr516","article-title":"Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?","volume":"27","author":"Soysal","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1378\/chest.12-0142_bib86","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03256394","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-\u03b1 antagonist therapy","volume":"14","author":"Kowada","year":"2010","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"10.1378\/chest.12-0142_bib87","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1378\/chest.12-0142_bib88","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","article-title":"French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.12-0142_bib89","series-title":"Natural Ventilation for Infection Control in Health-Care Settings","author":"Atkinson","year":"2009"},{"key":"10.1378\/chest.12-0142_bib90","series-title":"Guidelines on Airborne Infection Control in Healthcare and Other Settings","author":"Agarwal","year":"2010"},{"issue":"RR-11","key":"10.1378\/chest.12-0142_bib14","first-page":"19","article-title":"Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis","volume":"44","year":"1995","journal-title":"MMWR Recomm Rep"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212605224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212605224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:33:12Z","timestamp":1757917992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212605224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0012369212605224"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-0142","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relevance of Latent TB Infection in Areas of High TB Prevalence","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-0142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}